(Q44256476)

1 December 2017

title

Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes (English)

1 reference

1 December 2017

1 reference

M Cruz

1

1 reference

1 December 2017

C Maldonado-Bernal

2

1 reference

1 December 2017

R Mondragón-Gonzalez

3

1 reference

1 December 2017

R Sanchez-Barrera

4

1 reference

1 December 2017

N H Wacher

5

1 reference

1 December 2017

G Carvajal-Sandoval

6

1 reference

1 December 2017

J Kumate

7

1 reference

1 December 2017

publication date

1 August 2008

1 reference

Journal of Endocrinological Investigation

1 December 2017

published in

1 reference

1 December 2017

volume

31

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

694-699

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03346417

1 December 2017

exact match

0 references

cites work

Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Effect of glycine on insulin secretion and action in healthy first-degree relatives of type 2 diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Effect of glycine in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Inflammatory markers and risk of developing type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Is glycine effective against elevated blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Role of resistin in obesity, insulin resistance and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Glomerulotubular balance, dietary protein, and the renal response to glycine in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346417

Inhibition of hemoglobin glycation with glycine in induced diabetes mellitus in rats

21 January 2018

1 reference

12 December 2020

Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men

1 reference

12 December 2020

Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA)

1 reference

12 December 2020

Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression

1 reference

12 December 2020

The metabolic response to ingested glycine.

1 reference

12 December 2020

Glycine: a cell-protecting anti-oxidant nutrient

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346417

1 reference

1 December 2017

1 reference